AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
#INSIGHTSBYESMO
0 people · 0 posts
Floor
ESMO - Eur. Oncology@myESMO Philippe Aftimos, MD @aftimosp 引用@🔹Small improvement in mPFS with pembrolizumab (vs placebo) + chemotherapy in the KN-B49 ph3 study for endocrine resistant, PDL1+ (CPS≥1) HR+/HER2- MBC 🔹Bigger difference in CPS≥10: small numbers and a secondary endpoint 🔹No OS difference #ESMO2 #ESMOAmbassadors @myESMO